Supplementary Figure S9 from Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma
Year: 2025
Type: supplementary-materials
Abstract: Supplementary Figure S9 shows Lorlatinib potently downregulates multiple kinases involved in the G2/M cell cycle transition.
Authors: Smita Matkar, Michael P. East, Timothy J. Stuhlmiller, Gabriela M. Witek, Alvin Farrel, Steven Pastor, Denis O. Okumu, Anne Kennedy, Joshua R. Kalna, Esther R. Berko, Colleen E. Casey, Kateryna Krytska, Khushbu Patel, Jo Lynne Rokita, Mark Gerelus, John M. Maris, Gary L. Johnson, Yael P. Mossé
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4413905942